(Q43875898)

27 November 2017

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

0 references

A. Kalinkovich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

H. Engelmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

N. Harpaz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

R. Burstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

V. Barak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

I. Kalickman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

D. Wallach

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

Z. Bentwich

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325303

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1325303

13 September 2022

publication date

1 September 1992

1 reference

Clinical and Experimental Immunology

27 November 2017

1 reference

27 November 2017

89

1 reference

27 November 2017

3

1 reference

27 November 2017

351-355

1 reference

Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages

27 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06961.X

Prevalence of Cytomegalovirus Infection in Homosexual Men

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1992.TB06961.X

Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection

21 January 2018

1 reference

12 December 2020

Possible role of natural cytotoxic activity in the pathogenesis of AIDS

1 reference

12 December 2020

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

1 reference

12 December 2020

Cytokine regulation of HIV expression

1 reference

12 December 2020

Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease

1 reference

12 December 2020

The role of tumour necrosis factor-alpha in acquired immunodeficiency syndrome

1 reference

12 December 2020

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

12 December 2020

Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors

1 reference

12 December 2020

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

12 December 2020

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

12 December 2020

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

1 reference

12 December 2020

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients

1 reference

12 December 2020

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

1 reference

12 December 2020

Serum level of TNF alpha in HIV-infected individuals

1 reference

12 December 2020

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation

1 reference

12 December 2020

Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

1 reference

12 December 2020

Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1

1 reference

12 December 2020

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

1 reference

12 December 2020

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

12 December 2020

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

12 December 2020

The Walter Reed staging classification for HTLV-III/LAV infection.

1 reference

12 December 2020

Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublines

1 reference

12 December 2020

Role of Epstein-Barr virus in acquired immune deficiency syndrome

1 reference

12 December 2020

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

1 reference

12 December 2020

Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients

1 reference

12 December 2020

Mechanisms of bone loss: rheumatoid arthritis, periodontal disease and osteoporosis

1 reference

12 December 2020

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

TNF-alpha production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNF-alpha is one of the mediators causing lysis of HIV-infected T4 cells

1 reference

12 December 2020

Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion

1 reference

12 December 2020

Tumor necrosis factor: receptors and inhibitors

1 reference

12 December 2020

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients

1 reference

12 December 2020

Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients

1 reference

12 December 2020

Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children

1 reference

12 December 2020

Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro

1 reference

12 December 2020

An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease

1 reference

12 December 2020

Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity

1 reference

12 December 2020

Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

1 reference

12 December 2020

Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection

1 reference

12 December 2020

Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?

1 reference

12 December 2020

Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome

1 reference

12 December 2020

Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens

1 reference

12 December 2020

Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity

1 reference

12 December 2020

The role of cachectin/tumor necrosis factor in AIDS

1 reference

12 December 2020

Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome

1 reference

12 December 2020

10.1111/J.1365-2249.1992.TB06961.X

Identifiers

DOI

1 reference

27 November 2017

0 references

1 reference